Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
I am both a multiple myeloma (MM) survivor and MM cancer coach. I have been researching and writing about multiple myeloma for years. I can honestly say that MM patients and survivors must learn about and employ both conventional (FDA approved) and evidence-based non-conventional therapies if they are to manage their “incurable” blood cancer.
Curcumin is one of the best examples of an evidence-based non-conventional cancer therapy. The applications of this wonder therapy are too many to write about (but scroll down to read what Dr. Sukumar has to say).
Suffice to say that if you have been diagnosed with cancer, any cancer, you must learn about possible applications of this therapy to help you in the weeks, months and years ahead. In the age of super high tech oncology it is critical to learn about non-toxic therapies such as curcumin.
I supplement with Life Extension Super Bio Curcumin as this formula and brand are approved both for purity and bioavailability.
Please scroll down the page, post a question or comment and I will reply to you ASAP.
“In the present study, a large panel of human myeloma cell lines (HMCLs) (n = 29), representing the main molecular MM subgroups, was screened for curcumin sensitivity. We observed that curcumin cell death induction was heterogeneous, of note 16 HMCLs were highly sensitive to curcumin and only 7 HMCLs were weakly sensitive.
Cell lines harboring the t(11;14) translocation were less sensitive (median LD50 32.9 μM) than non-t(11;14) (median LD50 17.9 μM), which included poor prognosis t(4;14) and t(14;16) cells.
Interestingly, curcumin sensitivity was not dependent on TP53 status. For the first time we showed that primary myeloma cells were also sensitive, even those displaying del(17p), another poor prognosis factor.
Altogether, these results support clinical trials including curcumin in association with standard therapy.”
“There is definitely no shortage of scientific evidence these days to show that curcumin, the believed-to-be primary active ingredient in the spice turmeric, holds incredible therapeutic value, and just might be the most advisable medicinal spice of our day…